Treatment regimen allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Stem Cells Hematopoietic Stem Cells Antilymphocyte Serum T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Pluripotent Stem Cells Bone Marrow Cells Bone Marrow Neural Stem Cells Mesenchymal Stromal Cells CD8-Positive T-Lymphocytes Cells, Cultured Induced Pluripotent Stem Cells T-Lymphocytes, Cytotoxic Multipotent Stem Cells Philadelphia Chromosome Fetal Stem Cells CD4-Positive T-Lymphocytes Fetal Blood Killer Cells, Natural Lymphocytes T-Lymphocyte Subsets T-Lymphocytes, Regulatory Allografts Spermatogonia Neoplastic Stem Cells Plant Stems Blood Cells Dendritic Cells

Organisms9

Transplantation Chimera Cytomegalovirus Herpesvirus 6, Human Mice, Inbred C57BL Herpesvirus 4, Human Mice, Inbred BALB C Mice, SCID Radiation Chimera Chimera

Diseases48

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm, Residual Hepatic Veno-Occlusive Disease Acute Disease Primary Myelofibrosis Anemia, Aplastic Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Roseolovirus Infections Leukemia, Myeloid Lymphoproliferative Disorders Hodgkin Disease Lymphoma, Non-Hodgkin Infection Opportunistic Infections Stomatitis Adenoviridae Infections Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Chronic Disease Epstein-Barr Virus Infections Mycoses Blast Crisis Lymphoma, Follicular Aspergillosis Neoplasms Philadelphia Chromosome Viremia Neoplasm Recurrence, Local Disease Progression Severe Combined Immunodeficiency Lymphoma, Mantle-Cell Disease Models, Animal Blood Group Incompatibility Iron Overload Postoperative Complications Amyloidosis Neutropenia Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Chemicals and Drugs52

Myeloablative Agonists Busulfan Vidarabine Immunosuppressive Agents Minor Histocompatibility Antigens Antilymphocyte Serum Melphalan Cyclophosphamide HLA Antigens Antineoplastic Agents Cytarabine Antigens, CD34 Antibodies, Neoplasm Benzamides Fusion Proteins, bcr-abl Pyrimidines Receptors, Purinergic P2X5 Cyclosporine Piperazines Granulocyte Colony-Stimulating Factor Ganciclovir Antibodies, Monoclonal Etoposide Antibodies, Monoclonal, Murine-Derived Vincristine Benzydamine Antiviral Agents Antigens, CD Antibodies, Monoclonal, Humanized Stem Cell Factor Antigens, Viral Viral Matrix Proteins Antineoplastic Agents, Alkylating Carmustine DNA, Viral fms-Like Tyrosine Kinase 3 Thiotepa Thalidomide Methotrexate Prednisone Cytokines Isoantigens Biological Markers Antigens, Neoplasm Tacrolimus Antifungal Agents Doxorubicin HLA-A2 Antigen Interferon-gamma Recombinant Proteins Protein Kinase Inhibitors Dexamethasone

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Treatment Outcome Bone Marrow Transplantation Remission Induction Histocompatibility Testing Lymphocyte Transfusion Retrospective Studies Combined Modality Therapy Salvage Therapy Cord Blood Stem Cell Transplantation Disease-Free Survival Survival Analysis Whole-Body Irradiation Survival Rate Liver Transplantation Lymphocyte Depletion Antineoplastic Combined Chemotherapy Protocols Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Follow-Up Studies Cell Transplantation Prognosis Kidney Transplantation Immunosuppression Prospective Studies Fatal Outcome Immunotherapy, Adoptive Heart Transplantation Leukocyte Transfusion Flow Cytometry Transplantation, Isogeneic Risk Factors Immunotherapy Lymphocyte Count Lung Transplantation Actuarial Analysis Clinical Trials as Topic Polymerase Chain Reaction Cytogenetic Analysis Organ Transplantation Incidence Immunophenotyping Cohort Studies Islets of Langerhans Transplantation Transplantation Feasibility Studies Kaplan-Meier Estimate Cell Separation Viral Load Drug Therapy, Combination Reverse Transcriptase Polymerase Chain Reaction Pilot Projects Multivariate Analysis Drug Evaluation Pancreas Transplantation Drug Administration Schedule Leukapheresis Donor Selection Transplantation, Heterologous Lymphocyte Activation Predictive Value of Tests Bone Marrow Purging Treatment Failure Cell Culture Techniques Skin Transplantation Stem Cell Research Life Tables Disease Models, Animal Fetal Tissue Transplantation Transplantation, Heterotopic Cell- and Tissue-Based Therapy Risk Assessment Lymphocyte Culture Test, Mixed Blood Component Removal Case-Control Studies Platelet Transfusion Severity of Illness Index

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes29

Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Virus Activation Histocompatibility Time Factors Chimerism Transplantation Immunology Immunocompromised Host Graft Rejection Cell Differentiation Lymphocyte Count Stem Cell Niche T-Cell Antigen Receptor Specificity Cell Proliferation Philadelphia Chromosome Hematopoiesis Viral Load Cell Lineage Transplantation Tolerance Cytotoxicity, Immunologic Drug Resistance, Neoplasm Lymphocyte Activation Regeneration Karyotype Dose-Response Relationship, Drug Graft vs Host Reaction Radiation Chimera Cell Survival

Disciplines and Occupations2

Hematology Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Siblings Living Donors Blood Donors Unrelated Donors

Health Care25

Treatment Outcome Retrospective Studies Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Fatal Outcome Risk Factors Actuarial Analysis Clinical Trials as Topic Incidence Cohort Studies Feasibility Studies Kaplan-Meier Estimate Pilot Projects Multivariate Analysis Donor Selection Predictive Value of Tests Treatment Failure Life Tables Risk Assessment Case-Control Studies Age Factors Severity of Illness Index

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Hematologic Neoplasms Transplantation Chimera Stem Cells Treatment Outcome Bone Marrow Transplantation Graft vs Leukemia Effect Myeloablative Agonists Busulfan Tissue Donors Remission Induction Recurrence Vidarabine Graft vs Tumor Effect Graft Survival Histocompatibility Testing Lymphocyte Transfusion Immunosuppressive Agents Leukemia, Myeloid, Acute Retrospective Studies Multiple Myeloma Combined Modality Therapy Leukemia Siblings Salvage Therapy Cord Blood Stem Cell Transplantation Leukemia, Myelogenous, Chronic, BCR-ABL Positive Disease-Free Survival Cytomegalovirus Infections Hematopoietic Stem Cells Minor Histocompatibility Antigens Survival Analysis Whole-Body Irradiation Survival Rate Liver Transplantation Lymphocyte Depletion Antilymphocyte Serum Myelodysplastic Syndromes Virus Activation Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm, Residual Histocompatibility Antineoplastic Combined Chemotherapy Protocols Melphalan Cyclophosphamide Time Factors Chimerism Hepatic Veno-Occlusive Disease Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Cytomegalovirus T-Lymphocytes Acute Disease Follow-Up Studies Primary Myelofibrosis Anemia, Aplastic Cell Transplantation Prognosis Kidney Transplantation HLA Antigens Hematologic Diseases Embryonic Stem Cells Leukemia, Myeloid, Accelerated Phase Antineoplastic Agents Cytarabine Antigens, CD34 Antibodies, Neoplasm Transplantation Immunology Immunosuppression Benzamides Roseolovirus Infections Adult Stem Cells Immunocompromised Host Leukemia, Myeloid Lymphoproliferative Disorders Hodgkin Disease Fusion Proteins, bcr-abl Pyrimidines Receptors, Purinergic P2X5 Lymphoma, Non-Hodgkin Nuclear Family Graft Rejection Cyclosporine Piperazines Granulocyte Colony-Stimulating Factor Ganciclovir Infection Prospective Studies Fatal Outcome Immunotherapy, Adoptive Heart Transplantation Opportunistic Infections Antibodies, Monoclonal Etoposide

No FAQ available that match "treatment regimen allogeneic stem cell transplantation"